Skip to main content
. 2017 Jul 31;36(46):6383–6390. doi: 10.1038/onc.2017.256

Table 1. MST loci that can precisely differentiate between the lung cancer samples and non-tumor samples.

Genomic position Repeat Gene region Gene Entrez ID Disease Odds ratio
chr2:60918364-60918376 T Intron REL 5966 LUAD, LUSC 39.92
chr6:157174818-157174831 T Intron ARID1B 57 492 LUAD, LUSC, MB, SKCM 13.57
chr6:76018867-76018880 A Intron IMPG1 3617 LUSC, OV 12.28
chr3:94035443-94035458 T Intron ARL13B 200 894 GBM, LUAD, SKCM 11.20
chr3:112534347-112534360 A Intron ATG3 64 422 GBM, LGG, LUAD, LUSC 10.29
chr8:129862369-129862381 A Intron FAM49B 51 571 LUAD, LUSC 7.01
chr9:130622843-130622857 A Intron FUBP3 8939 GBM, LGG, LUAD, LUSC, MB, OV 6.93
chr7:135414296-135414309 A Intron CNOT4 4850 LUAD 5.07
chr2:48461120-48461133 T Intron KLRAQ1 129 285 LGG, LUAD, LUSC, MB, SKCM 4.43
chr2:55332516-55332530 A Intron CCDC88A 55 704 LUAD, LUSC, SKCM 3.90
chr13:31148484-31148500 A Intron HSPH1 3315 LUAD, SKCM 3.70
chr15:20458509-20458521 A Intron HERC2P3 283 755 LUAD 3.00
chr10:13591929-13591943 T Intron PRPF18 8559 LUSC 2.25
chr2:202815832-202815844 A Intron ICA1L 130 026 BC, GBM, OV 7.61
chr13:114236623-114236635 T Intron CDC16 8881 LGG, SKCM 6.19
chr12:106106383-106106396 A Intron NUAK1 9891 OV 5.74
chr3:98580864-98580876 A Intron CPOX 1371 BC, OV 5.02
chr16:70839964-70839978 T Intron HYDIN 54 768 GBM 4.58
chr2:233460070-233460083 A Intron DGKD 8527 OV 3.82
chr5:87383860-87383873 T Intron RASA1 5921 OV 2.93
chr8:23852057-23852082 TG Intron STC1 6781 BC 1.87

Abbreviations: GBM, glioblastoma; LGG, lower grade glioma; LUAD, lung adenocarcinoma; LUSC, lung squamous cell carcinoma. MB, medulloblastoma; OV, ovarian cancer; SKCM, skin cutaneous melanoma.